2006
DOI: 10.1016/j.neuint.2005.12.019
|View full text |Cite
|
Sign up to set email alerts
|

Single and combined effects of carbamazepine and vinpocetine on depolarization-induced changes in Na+, Ca2+ and glutamate release in hippocampal isolated nerve endings

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
22
0

Year Published

2007
2007
2016
2016

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 22 publications
(22 citation statements)
references
References 43 publications
0
22
0
Order By: Relevance
“…Table 1). ] i changes (Tretter and Adam-Vizi, 1998;Zelles et al, 2001;Sitges et al, 2006). Importantly, Vinpocetine did not influence the amplitude of the initial glutamate-evoked [Ca 2+ ] i rise indicating that Vinpocetine acts at least partially by influencing mechanisms controlling elevated [Ca 2+ ] i levels.…”
Section: Discussionmentioning
confidence: 97%
See 2 more Smart Citations
“…Table 1). ] i changes (Tretter and Adam-Vizi, 1998;Zelles et al, 2001;Sitges et al, 2006). Importantly, Vinpocetine did not influence the amplitude of the initial glutamate-evoked [Ca 2+ ] i rise indicating that Vinpocetine acts at least partially by influencing mechanisms controlling elevated [Ca 2+ ] i levels.…”
Section: Discussionmentioning
confidence: 97%
“…Vinpocetine can block phosphodiesterase I, which can be important for improvement of cerebral circulation (Pelligrino and Wang, 1998) and can act as an antioxidant . Vinpocetine also blocks voltage-gated sodium channels (VDSCs) in therapeutically relevant concentrations (<50 mM), decreases the Ca 2+ influx evoked by VDSC stimulation and can also attenuate Ca 2+ -dependent destructive processes (Lakics et al, 1995;Tretter and Adam-Vizi, 1998;Sitges and Nekrassov, 1999;Zelles et al, 2001;Sitges et al, 2006). Table 1). ]…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Vinpocetine (ethyl apovincamine-22-oate) is a nootropic drug with neuroprotective capabilities discovered during the late 1960s that in animal models of hypoxia and ischemia exerts beneficial effects against neuronal damage and has been used in the treatment of central nervous system disorders of cerebral-vascular origin for decades. In brain isolated nerve endings vinpocetine inhibited the rise in the internal concentration of Na + and neurotransmitter release induced by veratridine (Tretter & Adam-Vizi, 1998;Sitges & Nekrassov, 1999;Trejo et al, 2001;Sitges et al, 2006), as well as the tetrodotoxin sensitive fraction of the rise in Na + and Ca 2+ induced by 4-aminopyridine . In hippocampus isolated nerve endings, vinpocetine inhibited glutamate release induced by increasing presynaptic Na + channels permeability with veratridine and by increasing presynaptic Ca 2+ channels permeability with high K + in a much lower range of concentrations than carbamazepine, phenytoin, lamotrigine and oxcarbazepine (Sitges et al, 2007a;2007b).…”
Section: Effect Of the New Potential Antiepileptic Drug Vinpocetine Omentioning
confidence: 98%
“…In hippocampal synaptosomes preloaded with radioactive Glu ([ 3 H]Glu) several of the most amply used antiepileptic drugs and the new potential antiepileptic vinpocetine (ethyl apovincamine-22-oate) inhibited [ 3 H]Glu release induced by veratridine in the absence of external Ca 2+ ; vinpocetine being the most potent [6,7]. Also in the guinea pig in vivo phenytoin and carbamazepine were less potent than vinpocetine to inhibit the epileptic cortical activity induced by the convulsing agent, pentylenetetrazole [8].…”
Section: Introductionmentioning
confidence: 99%